Table 2.
Utilization of Screening Tests
| Variable | Commercially insured |
Medicaid insured |
|---|---|---|
| Breast cancer (women aged 40–59 years), n | 1,538,444 | 78,897 |
| Screening mammogram | ||
| 0 | 276,446 (18.0) | 30,208 (38.3) |
| 1 | 212,893 (13.8) | 18,007 (22.8) |
| 2 | 207,263 (13.5) | 12,009 (15.2) |
| ≥3 | 841,842 (54.7) | 18,673 (23.7) |
| 3 | 213,603 (13.9) | 7,573 (9.6) |
| 4 | 220,706 (14.3) | 5,404 (6.8) |
| ≥5 | 407,533 (26.5) | 5,696 (7.2) |
| Any healthcare encounter | 261,372 (94.5) | 29,529 (97.8) |
| ≥3 | 841,842 (54.7) | 18,673 (23.7) |
| ≥5 | 407,533 (26.5) | 5,696 (7.2) |
| ≥3 (among those aged 50–59 years) | 459,044 (56.7) | 9,905 (27.1) |
| Longest gap between mammograms, days, mean (SD) | 1,051.2 (655.7) | 1,451.2 (705.2) |
| Gap >1.5 years | 1,104,017 (71.8) | 67,945 (86.1) |
| Gap >2.5 years | 667,524 (43.4) | 54,324 (68.9) |
| Cervical cancer (women aged 30–59 years), n | 2,042,752 | 127,076 |
| Pap tests | ||
| 0 | 453,168 (22.2) | 52,973 (41.7) |
| 1 | 378,741 (18.5) | 34,145 (26.9) |
| ≥2 | 1,210,843 (59.3) | 39,958 (31.4) |
| 2 | 374,388 (18.3) | 20,797 (16.4) |
| 3 | 307,077 (15.0) | 11,197 (8.8) |
| 4 | 248,983 (12.2) | 5,306 (4.2) |
| ≥5 | 280,395 (13.7) | 2,658 (2.1) |
| Any healthcare encounter | 435,446 (96.1) | 51,570 (97.4) |
| ≥2 | 1,210,843 (59.2) | 39,958 (31.4) |
| ≥5 | 280,395 (13.7) | 2,658 (2.1) |
| Longest gap between Pap tests, mean (SD) | 1,136.3 (677.7) | 1,467.7 (722.5) |
| Gap >3.5 years | 691,647 (33.9) | 72,570 (57.1) |
| Received HPV co-testa | 922,134 (45.1) | 32,911 (25.9) |
| Co-test % among women with ≥1 Pap | (58.0) | (44.4) |
| Received no HPV co-test | 1,120,618 (54.9) | 94,165 (74.1) |
| Gap >3.5 years | 550,953 (49.2) | 63,011 (66.9) |
| Any healthcare encounter | 2,025,030 (99.1) | 125,673 (98.9) |
| Colorectal cancer (women aged 50–59 years), n | 809,521 | 36,587 |
| Colorectal cancer screening | 512,260 (63.3) | 17,259 (47.2) |
| No screening mammogram, Pap, or colorectal screening | 84,507 (10.4) | 8,067 (22.0) |
Notes: All values represent n (%), unless otherwise specified.
a
Co-testing: Pap and HPV test conducted on the same day.
HPV, human papilloma virus.